- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of clozapine-associated weight gain: a systematic review
Authors
Keywords
Adjunct medication, Antipsychotic, Clozapine, Obesity, Psychosis, Weight gain
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 71, Issue 4, Pages 389-401
Publisher
Springer Nature
Online
2015-01-27
DOI
10.1007/s00228-015-1807-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials
- (2014) Diarmid Sinclair et al. BMC Psychiatry
- Emerging drugs for schizophrenia: an update
- (2014) Luisa-Sophie Köster et al. EXPERT OPINION ON EMERGING DRUGS
- A fatal case of ischemic colitis during clozapine administration
- (2014) Trino Baptista REVISTA BRASILEIRA DE PSIQUIATRIA
- Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
- (2014) Nevena Divac et al. Biomed Research International
- Antipsychotic polypharmacy increases metabolic dysregulation in female rats.
- (2013) Heidi N. Boyda et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight
- (2013) Chun-Hsin Chen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine
- (2013) Heidi N. Boyda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A systematic review of the evidence of clozapine's anti-aggressive effects
- (2012) Catherine Frogley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats
- (2012) Heidi Boyda et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
- (2012) Joanne Y.T. Leung et al. PHARMACOLOGY & THERAPEUTICS
- Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far?
- (2012) Rasmus Røge et al. SCHIZOPHRENIA RESEARCH
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Topiramate-induced weight loss: A review
- (2011) Alberto Verrotti et al. EPILEPSY RESEARCH
- Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
- (2011) David C. Henderson et al. SCHIZOPHRENIA RESEARCH
- Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders
- (2010) Jurjen J Luykx et al. Expert Opinion On Drug Safety
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2010) Evgueni Tchoukhine et al. JOURNAL OF CLINICAL PSYCHIATRY
- Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting
- (2010) Ric M. Procyshyn et al. JOURNAL OF CLINICAL PSYCHIATRY
- Topiramate Augmentation in Clozapine-Treated Patients With Schizophrenia
- (2010) Margaret K. Hahn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
- (2010) Dimitris Repantis et al. PHARMACOLOGICAL RESEARCH
- A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model
- (2010) Heidi N. Boyda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Preclinical models of antipsychotic drug-induced metabolic side effects
- (2010) Heidi N. Boyda et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain
- (2009) Trino Baptista et al. CNS DRUGS
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
- (2009) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
- (2008) C. Torrent et al. ACTA PSYCHIATRICA SCANDINAVICA
- Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials
- (2008) Mario Álvarez-Jiménez et al. BRITISH JOURNAL OF PSYCHIATRY
- Metformin therapy and clinical uses
- (2008) John HB Scarpello et al. Diabetes & Vascular Disease Research
- Approved and Investigational Uses of Modafinil
- (2008) Raminder Kumar DRUGS
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?
- (2008) Leslie Citrome et al. POSTGRADUATE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started